Fresenius Medical Care AG & Co. KGaA (ADR) (NYSE:FMS)

CAPS Rating: 5 out of 5

The Company is engaged in the manufacture and sale of products for all forms of kidney dialysis, to health care providers throughout the world, and in providing kidney dialysis treatment and other medical ancillary services.

Recs

1
Player Avatar pharos60 (67.80) Submitted: 1/1/2007 10:22:09 PM : Outperform Start Price: $42.25 FMS Score: +59.70

Fresenius is the largest provider of dialysis services through their clinics. Thye ill continue to do well.

Featured Broker Partners


Advertisement